Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06890533

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery

The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Pain Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Cangzhou Central Hospital, Cangzhou, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be able to understand the study purpose and cooperate with the study procedures of this trial, voluntarily provide written informed consent
  • Body mass index (BMI) ≥18 kg/m2 and ≤28 kg/m2.
  • ASA I - II
  • Experiences a pain intensity rating of moderate to severe acute pain following abdominal surgery, with a pain intensity score of ≥4 on a Numeric Rating Scale (NRS) within 4 hours post-surgery

Exclusion criteria

  • Allergy to opioids and other medications that may be used during the trial.
  • Nervous system disorders (e.g. epilepsy)
  • Psychiatric disorders (e.g. depression)
  • History of difficult airways
  • Random blood glucose ≥11.1 mmol/L
  • Uncontrolled blood pressure [e.g., hypertension (systolic blood pressure ≥160 mmHg, diastolic blood pressure ≥100 mmHg)，or hypotension(systolic blood pressure <90 mmHg)]
  • Abnormal pulse oxygen saturation (SpO2 <90 %)
  • Abnormal liver function or renal function
  • Used agents that could affect the analgesic response
  • Used agents that could affect drug metabolism
  • Has previously participated in another YZJ-4729 clinical study

Treatment and study plan

Experimental: YZJ-4729

Drug

Loading dose + demand dose

Placebo Comparator: Saline

Drug

Loading dose + demand dose

Active Comparator: Morphine

Drug

Loading dose + demand dose

Primary outcomes

  1. the Sum of Pain Intensity Differences Over 24 Hours at rest

    Time frame: 24 hours

    Pain intensity will be evaluated using an 11-point (0-10) Numeric Pain Rating Scale (NRS), with higher numbers indicating a higher pain intensity, administered over 24 hours.

Secondary outcomes

  1. The Time to first using rescue analgesics

    Time frame: 24 hours

  2. The proportion of subjects using rescue analgesics

    Time frame: 24 hours

  3. The number of times for rescue analgesics using

    Time frame: 24 hours

  4. The cumulative dose used of rescue analgesics

    Time frame: 24 hours

  5. the resting Sum of Pain Intensity Differences Over 6、12、18、12-24 Hours

    Time frame: 24 hours

  6. the active Sum of Pain Intensity Differences Over 6、12、18、24、12-24 Hours

    Time frame: 24 hours

  7. Participant satisfaction scores for analgesia treatment

    Time frame: 24 hours

    Participants recalled the postoperative analgesia effect and rated their satisfaction on a scale of 1 to 5, with 1 representing dissatisfied and 5 representing very satisfied.

  8. Investigator satisfaction scores for analgesia treatment

    Time frame: 24 hours

    Postoperative analgesia was evaluated by investigators. The scale ranges from 1 to 5, with 1 being dissatisfied and 5 being very satisfied.

Sponsors and collaborators

Lead sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Industry

Registry information

Official study title

A Phase Ⅲ, Randomized, Double-Blind, Placebo- and Active-controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Abdominal Surgery

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 24, 2025
Registry last updated
Jun 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.